Drugs / HepeX-B
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00228592 | ? → Aug 2005 | hepatitis B virus infection | Merck & Co., Inc. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HepeX-B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00228592 ↗ |